Minerva Neurosciences
NERV
$2.37
Share price
-0.84%
Change (1 day)
-48.59%
Change (1 year)
Categories
Minerva Neurosciences (NERV) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $85.35 M
According to Minerva Neurosciences 's latest financial reports the company's total liabilities are $85.35 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Minerva Neurosciences - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $85.35 M | 13.64% |
| 2022-12-31 | $75.11 M | 8.63% |
| 2021-12-31 | $69.14 M | 1293.06% |
| 2020-12-31 | $4.96 M | -90.02% |
| 2019-12-31 | $49.71 M | 1.74% |
| 2018-12-31 | $48.87 M | -6.2% |
| 2017-12-31 | $52.1 M | 93.25% |
| 2016-12-31 | $26.96 M | -1.09% |
| 2015-12-31 | $27.25 M | 60.8% |
| 2014-12-31 | $16.95 M | 88.44% |
| 2013-12-31 | $8.99 M | 4627.09% |
| 2012-12-31 | $0.19 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Incyte INCY | $1.59 B | 1,765.42% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $0.37 B | 339.36% | 🇺🇸 USA |
 Clovis Oncology CLVS | $0.76 B | 795.84% | 🇺🇸 USA |